News
-
-
-
COMMUNIQUÉ DE PRESSE
aap confirms growth course at the start of 2026 – revenue slightly above previous year, strong momentum in the USA
aap Implantate AG reports positive sales growth in Q1 2026, USA drives revenue increase, certifications completed for CE markets, resilient business model in geopolitical challenges -
-
-
COMMUNIQUÉ DE PRESSE
aap Implantate AG closes financial year 2025 with earnings improvement and provides outlook for 2026
aap Implantate AG closes financial year 2025 with earnings improvement and provides outlook for 2026. Details on sales growth, regions, key financial figures, and future plans outlined -
-
-
COMMUNIQUÉ DE PRESSE
aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
aap Implantate AG successfully completes MDR certification for all existing products, ensuring market access in EU and CE-relevant markets in the long term. Focus shifts to new product development -
